Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This trial is a Phase 2, randomized, controlled study to compare the degree of mucosal injury after the oral administration of an investigational product, PL2200, and a marketed 325 mg immediate-release aspirin product.
Epistemonikos ID: 305a8c6dba6c5bf77ef29dd726502160e685321b
First added on: May 11, 2024